By proceeding, you agree to our Terms of Use and Privacy Policy.
Anastasia Khvorova, Ph.D., has more than 20 years of experience developing oligonucleotide technology and therapeutics.
Talks About #oligonucleotidetechnology
Preferred Locations #NorthAmerica
The International mRNA Health Conference (Conference Days, 8-10 November 2022) is the premier meeting destination for industry and academic professionals to explore the rapidly advancing science and business of mRNA medicines.